Loading…
Based on limited metadata, this FDA Warning Letter issued to Pharmalab Enterprises, Inc. on December 10, 2019 concerns drug manufacturing or distribution operations. While the specific violations cannot be detailed without access to the full letter text, the warning indicates the company failed to meet FDA standards for drug products under federal regulations. The letter was issued by the FDA's drug enforcement division, though the specific issuing office is not identified in this metadata summary.